USP11 deubiquitinates GATA3 to suppress the growth and metastasis of luminal-type breast cancers
Journal of Biological Chemistry · 2026-09 · 302 (9) · 113371
DOI: 10.1016/j.jbc.2026.113371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-09. Verfasst von Tao Qian und 14 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Infection Immunity and Inflammation, International Cancer Center, Marshall Laboratory of Biomedical Engineerin…. Hauptthemen laut MEDLINE: GATA3 Transcription Factor, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Guangdong Provincial Applied Science and Technology Research and Development Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Luminal breast cancers account for 70%-80% of total breast cancer cases. More than half of luminal breast cancers either relapse after treatment or lose their luminal features, resulting in poorly differentiated cancers with enhanced invasiveness and metastasis, yet the mechanisms remain largely elusive. In this study, we demonstrated that Ubiquitin-specific protease 11 (USP11) suppresses the proliferation and migration of luminal epithelial and tumor cells in vitro, but not basal-like tumor cells. Consistently, USP11 inhibits luminal tumorigenesis and metastasis, but promotes basal-like tumorigenesis in vivo. Mechanistically, USP11 positively regulates GATA3, p27, and ERα in a deubiquitinase activity-dependent manner. USP11 deubiquitinates GATA3, which subsequently binds to and transcriptionally activates CDKN1B (encoding p27). USP11 stimulates CDKN1B and ESR1 (encoding ERα) transcription in a GATA3-dependent manner. GATA3 knockdown reverses the increase in p27 and ERα and the decrease in cell proliferation and migration induced by USP11 overexpression, and p27 knockdown rescues the proliferative inhibition induced by USP11 or GATA3 overexpression in luminal tumorigenesis. USP11 overexpression sensitizes luminal breast cancer cells to tamoxifen treatment. The expression levels of USP11, GATA3, p27, and ERα are positively correlated with each other in human breast tumors and cell lines. We thus identify a novel USP11-GATA3 axis that governs luminal cell fate and restrains luminal cell proliferation and migration during mammary tumor development and metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Infection Immunity and Inflammation, International Cancer Center, Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University General Hos…
- Gansu Dian Medical Laboratory, Lanzhou, China.
- Guangdong Key Laboratory for Genome Stability & Disease Prevention and International Cancer Center, Shenzhen University Medical School, Shenzhen, Guangdong, China; Shenzhen-Almaty Joint Laboratory for Frontiers in Medic…
- Shenzhen-Almaty Joint Laboratory for Frontiers in Medical Science (salFMS), Shenzhen University Medical School, Shenzhen, Guangdong, China; Department of Health Policy and Organization, Al-Farabi Kazakh National Univers…
- Department of Public Health and Healthcare Management, Samarkand State Medical University, Samarkand, Uzbekistan.
- Department of Biochemistry and Molecular Biology, International Cancer Center, Shenzhen University Medical School, Shenzhen, Guangdong, China.
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Guangdong Provincial Applied Science and Technology Research and Development Program
- National Natural Science Foundation of China
Zitieren
APA
Qian, T., Liu, X., Bai, F., He, Q., Xu, Y., Zhang, J., Zhang, S., Ye, S., Wang, Y., Peng, B., Gulnara, K., Rizaev, J., Zhu, W. G., Xu, X., & Pei, X. H. (2026). USP11 deubiquitinates GATA3 to suppress the growth and metastasis of luminal-type breast cancers. Journal of Biological Chemistry, 302(9), 113371. https://doi.org/10.1016/j.jbc.2026.113371
Vancouver
Qian T, Liu X, Bai F, He Q, Xu Y, Zhang J, et al. USP11 deubiquitinates GATA3 to suppress the growth and metastasis of luminal-type breast cancers. Journal of Biological Chemistry. 2026;302(9):113371. doi:10.1016/j.jbc.2026.113371
BibTeX
@article{Qian2026,
author = {Qian, Tao and Liu, Xiong and Bai, Feng and He, Qiyue and Xu, Yipei and Zhang, Jiayi and Zhang, Shiwen and Ye, Shaoling and Wang, Yuchan and Peng, Bin and Gulnara, Kapanova and Rizaev, Jasur and Zhu, Wei-Guo and Xu, Xingzhi and Pei, Xin-Hai},
title = {USP11 deubiquitinates GATA3 to suppress the growth and metastasis of luminal-type breast cancers},
journal = {Journal of Biological Chemistry},
year = {2026},
volume = {302},
number = {9},
pages = {113371},
doi = {10.1016/j.jbc.2026.113371}
}
EUVIMED